TAK

NYSEStock

Takeda Pharmaceutical Company Limited

$17.75-0.03 (-0.14%)

52-Week Range

$13.23
$18.80

Key Stats

Market Cap

P/E Ratio

Dividend Yield

3.31%

Beta

0.10

Volume

2.1M

Avg Volume

2.5M

Performance

1M

-3.74%

3M

+21.63%

6M

+17.53%

YTD

+13.76%

1Y

+17.06%

3Y

+8.09%

5Y

-6.03%

Price Chart

ETF Exposure

TAK is held by 18 ETFs

ETFFund NameWeight
PPHVanEck Pharmaceutical ETF2.93%
IDVOAmplify CWP International Enhanced Dividend Income ETF1.54%
BADB.A.D. ETF1.51%
GERMETFMG Treatments, Testing and Advancements ETF0.89%
GINXSGI Enhanced Global Income ETF0.86%
FVLFirst Trust Value Line 100 Exchange-Traded Fund0.42%
FVDFirst Trust Value Line Dividend Index Fund0.42%
AVSDAvantis Responsible International Equity ETF0.07%
BDYNiShares Dynamic Equity Active ETF0.06%
AVDEAvantis International Equity ETF0.06%
AVTMAvantis Total Equity Markets ETF 10.01%
VALTETFMG Sit Ultra Short ETF0.00%
VEU.AXVanguard All-World ex-U.S. Shares Index ETF0.00%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.00%
VEUVanguard FTSE All-World ex-US ETF0.00%
AFTYPacer CSOP FTSE China A50 ETF0.00%
DFAXDimensional - World ex US Core Equity 2 ETF0.00%
DFICDimensional - International Core Equity 2 ETF0.00%

About TAK ETF Exposure

Takeda Pharmaceutical Company Limited (TAK) is held by 18 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $17.75 with a dividend yield of 3.31%. Investors can gain exposure to TAK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TAK, sorted by portfolio weight.